Xtant Medical Holdings Inc (XTNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,023 | -8,221 | -70,099 | -52,411 | -19,494 |
| Depreciation Amortization | 2,079 | 3,143 | 6,590 | 8,409 | 7,242 |
| Accounts receivable | 2,890 | -647 | 2,536 | 4,747 | -2,680 |
| Accounts payable and accrued liabilities | 101 | -4,278 | -3,011 | -1,637 | 319 |
| Other Working Capital | -3,273 | -2,557 | 931 | 3,300 | -8,996 |
| Other Operating Activity | 4,495 | 12,147 | 64,265 | 37,049 | 9,201 |
| Operating Cash Flow | $-731 | $-413 | $1,212 | $-543 | $-14,407 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,304 | -544 | -367 | -1,608 | -5,816 |
| Investing Cash Flow | $-1,304 | $-544 | $-367 | $-1,608 | $-5,816 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 10,253 |
| Debt Issued | N/A | N/A | N/A | 12,787 | 3,238 |
| Debt Repayment | -471 | -455 | -359 | -88 | -145 |
| Common Stock Issued | 668 | N/A | 1 | 178 | 3,088 |
| Other Financing Activity | -1,058 | -148 | 3,454 | -10,448 | 0 |
| Financing Cash Flow | $-861 | $-603 | $3,096 | $2,429 | $16,434 |
| Beginning Cash Position | 5,237 | 6,797 | 2,856 | 2,578 | 6,368 |
| End Cash Position | 2,341 | 5,237 | 6,797 | 2,856 | 2,578 |
| Net Cash Flow | $-2,896 | $-1,560 | $3,941 | $278 | $-3,790 |
| Free Cash Flow | |||||
| Operating Cash Flow | -731 | -413 | 1,212 | -543 | -14,407 |
| Capital Expenditure | -1,545 | -879 | -624 | -1,641 | -5,833 |
| Free Cash Flow | -2,276 | -1,292 | 588 | -2,184 | -20,240 |